Outlook Therapeutics, Inc.
NASDAQ:OTLK
1.825 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -75,366,714 | -58.983 | -66.052 | -53.163 | -35.239 | -34.524 | -46.115 | -38.849 | -53.329 | -48.67 | -13.732 |
| Depreciation & Amortization
| 113,859 | 0.044 | 0.205 | 0.262 | 0.554 | 3.362 | -3.054 | 2.692 | 2.394 | 1.825 | 0.878 |
| Deferred Income Tax
| 0 | 0 | 0 | 0.498 | 2.239 | 9.439 | 20.146 | -3.097 | 0.014 | 0 | 0 |
| Stock Based Compensation
| 5,385,124 | 5.547 | 7.711 | 4.887 | 2.807 | 1.313 | 1.986 | 8.571 | 12.45 | 11.178 | 3.958 |
| Change In Working Capital
| -3.018 | 4.753 | -1.684 | -7.079 | -1.27 | -13.195 | -13.682 | 11.163 | -7.025 | 8.179 | 1.863 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | -0.02 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.221 | 1.086 | 0 |
| Accounts Payables
| 1.394 | 3.083 | 1.295 | -0.198 | -1.49 | -1.332 | -6.714 | 5.727 | -5.326 | 6.581 | -0.096 |
| Other Working Capital
| -4.412 | 1.67 | -2.98 | -6.881 | 0.22 | -11.863 | -6.968 | 5.435 | -1.497 | 0.532 | 1.959 |
| Other Non Cash Items
| 1,073,876.018 | 5.665 | 3.147 | 0.342 | -0.881 | 1.314 | 7.68 | 4.015 | 0.013 | 0.012 | 0.012 |
| Operating Cash Flow
| -68,793,858 | -42.973 | -56.675 | -54.253 | -31.79 | -32.29 | -33.04 | -15.505 | -45.483 | -27.476 | -7.02 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| 0 | -0 | 0 | 0 | 0 | -0.437 | -2.781 | -0.292 | -1.098 | -8.804 | -2.367 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | -0.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | -0.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | -0.9 | -0.437 | -2.781 | -0.292 | -1.098 | -8.804 | -2.367 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -0.004 | 19.768 | -2.319 | 6.307 | 0.641 | -6.944 | -0.991 | 11.331 | -13.345 | 1.579 | 4.388 |
| Common Stock Issued
| 60.334 | 30.024 | 62.307 | 46.302 | 35.431 | 45.965 | 14.695 | 1.607 | 53.213 | 41.25 | 11.043 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.226 | -4.128 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | -1,886,945 | -16,985 | 0 | 0 | 0 |
| Other Financing Activities
| 60,329,353.671 | -0.824 | -0.394 | 3.585 | 1.139 | 0.004 | 20.648 | 16,988.692 | -0.006 | 0.173 | 7.109 |
| Financing Cash Flow
| 60,329,414 | 48.969 | 59.594 | 56.195 | 37.211 | 39.025 | 34.353 | 16.631 | 39.862 | 43.002 | 11.474 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -8,464,444 | 5.995 | 2.919 | 1.941 | 4.52 | 6.298 | -1.468 | 0.834 | -6.719 | 6.722 | 2.087 |
| Cash At End Of Period
| 14,927,538 | 23.392 | 17.397 | 14.477 | 12.536 | 8.016 | 1.717 | 3.186 | 2.352 | 9.071 | 2.349 |